Maximizing Minimally Invasive Cardiac Surgery With Enhanced Recovery (ERAS).

We convened a group of cardiac surgeons, intensivists, and anesthesiologists with extensive experience in minimally invasive cardiac surgery (MICS) and perioperative care to identify the essential elements of a MICS program and the relationship with Enhanced Recovery After Surgery (ERAS). The MICS incision should minimize tissue invasion without compromising surgical goals. MICS also requires safe management of hemodynamics and preservation of cardiac function, which we have termed

Déclaration de conflit d'intérêts

Declaration of Conflicting InterestsThe authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: R.S. discloses advisory/consultancy roles with Arthrex, Zimmer Biomet, AtriCure, Encare, La Jolla, Edwards Lifesciences, Terumo. N.A. discloses advisory roles for Genesee Biomedical, Cardiosight, VGS, consultant for AtriCure, consultant with stock options Pulse Biosciences, co-founder Left Atrial Appendage, LLC. H.H.B. discloses role as proctor with Intuitive, Corcym, and Edwards Lifesciences. S.L.M. is a consultant for Medtronic, Artivion, and Johnson & Johnson. P.S.N. is the inventor of various simulators commercialized by Simurghy and reports consultancy agreements with NeoChord, Edwards Lifesciences, Medtronic, Abbott, and Fujifilm. J.K. has received speaker honoraria from Edwards Lifesciences, Medtronic, Artivion, and Abbott. N.B. discloses speaker’s honoraria from Edwards Lifesciences and Medtronic, as well as research grants from Edwards Lifesciences and Corcym. V.B. is a consultant for Edwards Lifesciences, Medtronic, Abbott, and Boston Scientific. M.G. discloses advisory, consultancy, and/or research roles with Arthrex, Artivion, AtriCure, Abbott, Edwards Lifesciences, Corvivo, Corcym, and DASI Simulations. D.J. discloses consultancy for Edwards Lifesciences, Medtronic, Abbott, Artivion, and Corcym. D.T.E. discloses a Device Safety Monitoring Board role for Edwards Lifesciences, Medical Advisory Board for Astellas Pharma, Alexion, Terumo, Medela, Arthrex, and Renibus Therapeutics. All other authors have no disclosures.